Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 30,000 shares at $38.83 ($1.2M) on 2021-07-06, disclosed to the SEC on 2021-07-08.
Open-market sale of $1.2M ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.83 | 10,000 | $388K | 33.5% |
| 2 | $38.17 | 6,486 | $248K | 21.4% |
| 3 | $38.17 | 6,486 | $248K | 21.4% |
| 4 | $39.20 | 3,514 | $138K | 11.9% |
| 5 | $39.20 | 3,514 | $138K | 11.9% |
| Total | $38.63 avg | 30,000 |
| $1.2M |
| 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |